# Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy

> **NCT01947569** · PHASE1,PHASE2 · UNKNOWN · sponsor: **DiaVacs, Inc.** · enrollment: 90 (estimated)

## Conditions studied

- Treatment of Type I Diabetes Mellitus.

## Interventions

- **BIOLOGICAL:** Biological

## Key facts

- **NCT ID:** NCT01947569
- **Lead sponsor:** DiaVacs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2013-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947569, "Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01947569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*